Doximity, Inc. (NYSE: DOCS - Get Free Report) has been assigned a consensus rating of "Moderate Buy" from the twenty-two research firms that are covering the company, MarketBeat reports. Six analysts
Hims & Hers and Doximity are taking different paths in digital health, but which stock offers stronger upside now? Let's dive in.
SAN FRANCISCO--(BUSINESS WIRE)--Doximity, Inc. (NYSE: DOCS), the leading digital platform for U.S. medical professionals, today released a new report examining how physicians are adopting artificial i
ArrowMark Colorado Holdings LLC lowered its stake in shares of Doximity, Inc. (NYSE: DOCS) by 58.3% during the third quarter, according to the company in its most recent disclosure with the Securities
Capital World Investors lifted its holdings in Doximity, Inc. (NASDAQ: DOCS) by 25.7% during the undefined quarter, according to the company in its most recent Form 13F filing with the SEC. The firm o
Cresset Asset Management LLC decreased its holdings in shares of Doximity, Inc. (NASDAQ: DOCS) by 57.0% during the third quarter, according to its most recent Form 13F filing with the Securities and E
Eli Lilly and Company's shares rose during the quarter as Zepbound's obesity launch continued to gain strong traction. Cidara Therapeutics' shares rose further following Merck's acquisition of the com
Doximity, Inc. (NYSE: DOCS - Get Free Report) has earned an average recommendation of "Moderate Buy" from the nine brokerages that are covering the company, MarketBeat reports. Three analysts have rat
Doximity stock has fallen during the software stock bust in 2026. The business is doing well, is highly profitable, and has a lock on the doctor social media market in the United States.
Shareholders should contact the firm immediately as there may be limited time to enforce your rights Shareholders should contact the firm immediately as there may be limited time to enforce your right

Doximity: Growth Outlook Is Murky

09:13pm, Wednesday, 11'th Feb 2026
Doximity remains a Hold as growth visibility weakens and NRR declines to 112%, raising concerns over future expansion. Engagement and profitability are robust, with workflow tools reaching 720,000 uni
Allianz Asset Management GmbH acquired a new stake in Doximity, Inc. (NASDAQ: DOCS) during the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission.
William Blair sold 372,184 shares of Doximity; estimated trade size was $20.89 million (quarterly average pricing). Quarter-end Doximity position value fell by $184.77 million, reflecting both trading
Pre-Market Stock Futures: Futures are trading lower after an incredible turnaround on Friday, with all major indices surging higher following a three-day massive sell-off that had pushed the stock mar
Doximity, Inc. (NYSE: DOCS - Get Free Report) shares gapped down before the market opened on Friday. The stock had previously closed at $33.32, but opened at $23.69. Doximity shares last traded at $25
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE